The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I trial of tivantinib in combination with carboplatin and pemetrexed as first-line treatment in patients with advanced nonsquamous non small cell lung cancer or malignant pleural mesothelioma.
 
Paolo Andrea Zucali
No Relationships to Disclose
 
Matteo Simonelli
No Relationships to Disclose
 
Fabio De Vincenzo
No Relationships to Disclose
 
Giuseppe Fatuzzo
No Relationships to Disclose
 
Monica Bertossi
No Relationships to Disclose
 
Matteo Perrino
No Relationships to Disclose
 
Chiara Miggiano
No Relationships to Disclose
 
Laura Giordano
No Relationships to Disclose
 
Cristiana Bonifacio
No Relationships to Disclose
 
Federica Mrakic Sposta
No Relationships to Disclose
 
Armando Santoro
Consulting or Advisory Role - ArQule
Speakers' Bureau - ArQule
Research Funding - ArQule